- Open New Horizons With the International Journal of Heart Failure for Global Connection
-
Park SM
- KMID: 2536291
- Int J Heart Fail.
- 2022 Oct;4(4):175-176.
- doi: 10.36628/ijhf.2022.0024
-
- CITED
-
- Close
- SHARE
-
- Close
- Drug Titration for Patients With Heart Failure With Reduced Ejection Fraction Is a Challenge for Physicians in the Era of Four Pillar Drugs
-
Lee SH
- KMID: 2536293
- Int J Heart Fail.
- 2022 Oct;4(4):180-182.
- doi: 10.36628/ijhf.2022.0023
-
- CITED
-
- Close
- SHARE
-
- Close
- Renal Effects of SGLT2 Inhibitors and Potential Clinical Implications: Beyond the Heart
-
Lee S
- KMID: 2536292
- Int J Heart Fail.
- 2022 Oct;4(4):177-179.
- doi: 10.36628/ijhf.2022.0017
-
- CITED
-
- Close
- SHARE
-
- Close
- Acute Myocarditis After COVID-19 Vaccination
-
Cheon DY, Lee S, Park MS, Kim DY, Jung MH, Choi JH, Han S, Ryu KH
- KMID: 2536296
- Int J Heart Fail.
- 2022 Oct;4(4):205-208.
- doi: 10.36628/ijhf.2022.0019
-
- CITED
-
- Close
- SHARE
-
- Close
- Heart Failure and Diabetes Mellitus: Dangerous Liaisons
-
Lee HY
- KMID: 2536290
- Int J Heart Fail.
- 2022 Oct;4(4):163-174.
- doi: 10.36628/ijhf.2022.0022
Patients with diabetes mellitus (DM) have a higher prevalence of heart failure (HF) than those without it. Approximately 40% of HF patients have DM, having poorer outcomes than those without... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Empagliflozin on Diuretics Reduction in Outpatient Heart Failure Patients
-
Kim SJ, Kim BJ, Im SI, Kim HS, Heo JH
- KMID: 2536294
- Int J Heart Fail.
- 2022 Oct;4(4):183-192.
- doi: 10.36628/ijhf.2022.0009
Background and Objectives: Inhibitors of sodium–glucose cotransporter 2 (SGLT2i) reduce the risk of hospitalization for heart failure (HF). We aimed to examine the effect of empagliflozin on change of diuretics... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-World Usage of Sacubitril/ Valsartan in Korea: A Multi-Center, Retrospective Study
-
Park JJ, Lee SE, Cho HJ, Choi JO, Yoo BS, Kang SM, Wang HC, Lee S, Choi DJ
- KMID: 2536295
- Int J Heart Fail.
- 2022 Oct;4(4):193-204.
- doi: 10.36628/ijhf.2022.0015
Background and Objectives: Differences in drug prescriptions exist between clinical trials and real-world practice. We evaluated the real-world treatment patterns of sacubitril/ valsartan in Korean patients with heart failure (HF). Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
